The current COVID-19 pandemic influences many areas of social life, medical treatments and the way allergy is performed. Allergen-specific immunotherapy (AIT) is one of the most important treatment options for IgE-mediated allergies and is based on immunological effects on the diseased patient.

Cite as

Klimek, L., Jutel, M., Akdis, C., Bousquet, J., Akdis, M., Bachert, C., Agache, I., Ansotegui, I., Bedbrook, A., Bosnic-Anticevich, S., Canonica, G., Chivato, T., Cruz, A., Czarlewski, W., Del Giacco, S., Du, H., Fonseca, J., Gao, Y., Haahtela, T., Hoffmann‐Sommergruber, K., Ivancevich, J., Khaltaev, N., Knol, E., Kuna, P., Larenas-Linnemann, D., Melén, E., Mullol, J., Naclerio, R., Ohta, K., Okamoto, Y., O'Mahony, L., Onorato, G., Papadopoulos, N., Pawankar, R., Pfaar, O., Samolinski, B., Schwarze, J., Toppila-Salmi, S., Shamji, M., Ventura, M., Yorgancioglu, A., Matricardi, P. & Zuberbier, T. 2020, 'Handling of allergen immunotherapy in the COVID-19 pandemic:An ARIA-EAACI statement', Allergy, 75(7), pp. 1546-1554. https://doi.org/10.1111/all.14336

Downloadable citations

Download HTML citationHTML Download BIB citationBIB Download RIS citationRIS
Last updated: 28 June 2023
Was this page helpful?